Page 78 - Winter2020

cognitive deficits (such as memory loss and tion; in reality, however, even half a dozen pertussis vaccinations are not
sleep disturbances) and demyelinating central providing protection against the disease.
nervous system disorders like multiple scle- The fact is that fully vaccinated children, adolescents and adults
rosis. Aluminum adjuvants also contribute to remain susceptible to pertussis, with cases of whooping cough rising
autoimmune and inflammatory diseases such as steadily throughout the world since the 1980s, despite high vaccination
arthritis, type 1 diabetes, inflammatory bowel rates. A 2013 study, titled “Waning immunity to pertussis following five
disease, lupus and autism spectrum disorder. doses of DTaP,” summarized the state of affairs, finding that the risk of
Neil Miller’s excellent book, Miller’s Review of pertussis doubled just two years after Minnesota children received their
Critical Vaccine Studies, provides a summary fifth dose of DTaP and increased nine-fold within six years of full vac-
of twenty-seven studies revealing the damaging cination. Another study from 2015, titled “Tdap vaccine effectiveness
47
effects of aluminum, as well as many studies in adolescents during the 2012 Washington State pertussis epidemic,”
showing the dangers of vaccines against diph- found that within two to four years of receiving a sixth dose of acellular
theria, tetanus and pertussis. pertussis vaccine, the shot’s effectiveness in adolescents declined to 34
46
percent.
48
WANING IMMUNITY Experts commonly quote the efficacy of whole-cell pertussis vac-
When a person recovers from pertussis cines as being between 30 and 85 percent, and that of acellular pertussis
infection, natural immunity is thought to last vaccines as somewhere between 40 and 89 percent. However, an analysis
between seven and twenty years. Conversely, of a California whooping cough outbreak that occurred in 2010 revealed
estimates suggest that artificial vaccine-induced that more than 80 percent of those affected were fully vaccinated, and
immunity wanes as soon as two years after another 11 percent were partially vaccinated. A study of a 2007 U.S.
49
getting vaccinated with either whole-cell or Virgin Islands pertussis outbreak found that Tdap boosters were ineffec-
acellular pertussis-containing vaccines. This tive in providing temporary immunity for at least a third of vaccinated
8
rapid waning of pertussis vaccine immunity teenagers and adults.
50
is the reason that the CDC tells children and Furthermore, the vaccines may be even less effective than we think.
adolescents to undergo six rounds of vaccina- There is evidence that millions of U.S. children and adults asymptomati-

ACUTE AND CHRONIC DAMAGE FROM WHOLE-CELL PERTUSSIS VACCINES
By the early 1980s, multiple studies had confirmed the outsized risks of vaccines containing a whole-cell pertussis
component. In 1981, for example, British researchers published the largest case-control study ever conducted—the
8
British National Childhood Encephalopathy Study (NCES)—to investigate causes of brain damage in children. The
73
researchers concluded that the pertussis portion of the three-in-one DTP vaccine could cause acute brain inflamma-
tion and permanent brain damage and identified long-term brain dysfunction affecting physical, social, behavioral and
educational outcomes in vaccine-injured children. The NCES researchers estimated that the risk of a previously healthy
child developing a serious neurological problem or chronic brain dysfunction within seven days of DTP vaccination was
one per one hundred ten thousand shots and one per three hundred ten thousand shots, respectively. A University of
California-Los Angeles (UCLA) study conducted that same year (1981) in the U.S. found that an astounding one in eight
hundred seventy-five DTP shots was followed by either convulsion or shock within forty-eight hours of vaccination. 74
Another early 1980s study from West Africa’s Guinea-Bissau found that all-cause infant mortality after three months of
age increased by 212 percent after introduction of whole-cell DTP and oral polio vaccines.
75
In the U.S., the British study conclusions were confirmed by two congressionally mandated reviews by the Institute
of Medicine (IOM). IOM reports from 1991 and 1994 concluded that “evidence is consistent with a causal relation”
8
76
77
between DTP vaccine and acute brain inflammation and “unusual shock-like state”; and that “evidence indicates a
causal relationship between DTP vaccine and shock (anaphylaxis) and protracted, inconsolable crying.” The IOM also
confirmed the possibility that some children without underlying brain or metabolic abnormalities might experience
serious acute neurological illness within seven days of receiving a DTP vaccine.
Nor has neurological damage been the only type of outcome to worry about. In one of the very few U.S. studies
ever to explicitly compare vaccinated to unvaccinated children, UCLA School of Public Health researchers reported in
the year 2000 that DTP (or tetanus) vaccination was associated with a lifetime history of asthma or other allergy-related
symptoms. Shockingly, they estimated that 50 percent of diagnosed asthma cases (2.93 million) in U.S. children and
78
adolescents could be prevented if the DTP or tetanus vaccines were not administered.
76 Wise Traditions WINTER 2020